Drug Type Small molecule drug |
Synonyms Castrodin, Gastrodin, Gastrodini Synthici + [13] |
Target |
Mechanism GFAP inhibitors(Glial fibrillary acidic protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 2001), |
Regulation- |
Molecular FormulaC13H18O7 |
InChIKeyPUQSUZTXKPLAPR-UJPOAAIJSA-N |
CAS Registry62499-27-8 |
Start Date15 Sep 2022 |
Sponsor / Collaborator- |
Start Date27 Dec 2018 |
Sponsor / Collaborator |
Start Date17 Sep 2018 |
Sponsor / Collaborator |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Gastrodine | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Brain Injuries, Traumatic | CN | 01 Jan 2001 | |
Headache | CN | 01 Jan 2001 | |
Neurasthenia | CN | 01 Jan 2001 | |
Vertigo | CN | 01 Jan 2001 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Delirium | IND Approval | CN | 26 Feb 2025 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |